T-cell redirecting bispecific and trispecific antibodies in multiple myeloma beyond BCMA
NWCJ van de Donk, C O'Neill… - Current opinion in …, 2023 - journals.lww.com
Various T-cell redirecting BsAbs are in advanced stages of clinical development with
promising activity and a manageable toxicity profile. Ongoing studies are evaluating …
promising activity and a manageable toxicity profile. Ongoing studies are evaluating …